Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Evangelos Stelios Gragoudas, M.D.

Co-Author

This page shows the publications co-authored by Evangelos Gragoudas and Ivana Kim.
Connection Strength

5.635
  1. Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma. Trans Am Ophthalmol Soc. 2016 Aug; 114:T2.
    View in: PubMed
    Score: 0.697
  2. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010 Jul; 128(7):871-5.
    View in: PubMed
    Score: 0.457
  3. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010 Aug; 117(8):1617-22.
    View in: PubMed
    Score: 0.449
  4. Radiation therapy for neovascular age-related macular degeneration revisited. Br J Ophthalmol. 2009 Mar; 93(3):279-80.
    View in: PubMed
    Score: 0.417
  5. Melanocytoma of the optic nerve associated with sound-induced phosphenes. Arch Ophthalmol. 2006 Feb; 124(2):273-7.
    View in: PubMed
    Score: 0.337
  6. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field). Br J Ophthalmol. 2020 Dec 21.
    View in: PubMed
    Score: 0.236
  7. Conservative management of suspicious melanocytic lesions of the iris. Graefes Arch Clin Exp Ophthalmol. 2019 Jun; 257(6):1319-1324.
    View in: PubMed
    Score: 0.209
  8. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma. JAMA Ophthalmol. 2018 09 01; 136(9):981-986.
    View in: PubMed
    Score: 0.201
  9. Genetic Risk Factors for Radiation Vasculopathy. Invest Ophthalmol Vis Sci. 2018 03 01; 59(3):1547-1553.
    View in: PubMed
    Score: 0.194
  10. Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas. JAMA Ophthalmol. 2017 11 01; 135(11):1191-1196.
    View in: PubMed
    Score: 0.190
  11. Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma--Reply. JAMA Ophthalmol. 2016 Feb; 134(2):239-40.
    View in: PubMed
    Score: 0.168
  12. Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea. Ophthalmology. 2016 Feb; 123(2):369-377.
    View in: PubMed
    Score: 0.165
  13. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations. JAMA Ophthalmol. 2015 Aug; 133(8):881-7.
    View in: PubMed
    Score: 0.162
  14. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy. JAMA Ophthalmol. 2015 Jul; 133(7):792-6.
    View in: PubMed
    Score: 0.162
  15. Immunohistochemical investigations of adult intraocular medulloepitheliomas. Clin Exp Ophthalmol. 2015 May-Jun; 43(4):379-85.
    View in: PubMed
    Score: 0.154
  16. High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. Invest Ophthalmol Vis Sci. 2012 Oct 09; 53(11):6991-6.
    View in: PubMed
    Score: 0.134
  17. Proton irradiation for peripapillary and parapapillary melanomas. Arch Ophthalmol. 2011 Sep; 129(9):1127-30.
    View in: PubMed
    Score: 0.124
  18. Posterior uveal melanoma in young patients treated with proton beam therapy. Retina. 2010 Sep; 30(8):1267-71.
    View in: PubMed
    Score: 0.116
  19. Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010 Aug; 128(8):996-1000.
    View in: PubMed
    Score: 0.115
  20. Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas. Ophthalmologica. 2010; 224(4):209-16.
    View in: PubMed
    Score: 0.110
  21. Ocular melanocytoma. Int Ophthalmol Clin. 2009; 49(1):165-75.
    View in: PubMed
    Score: 0.103
  22. Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest Ophthalmol Vis Sci. 2008 Jun; 49(6):2599-605.
    View in: PubMed
    Score: 0.097
  23. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci. 2006 Jan; 47(1):357-63.
    View in: PubMed
    Score: 0.084
  24. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin. Invest Ophthalmol Vis Sci. 2021 04 01; 62(4):3.
    View in: PubMed
    Score: 0.060
  25. Reply. Ophthalmol Retina. 2021 03; 5(3):e4.
    View in: PubMed
    Score: 0.060
  26. Evaluation of choroidal lesions with swept-source optical coherence tomography. Br J Ophthalmol. 2019 01; 103(1):88-93.
    View in: PubMed
    Score: 0.049
  27. Systematic genomic and translational efficiency studies of uveal melanoma. PLoS One. 2017; 12(6):e0178189.
    View in: PubMed
    Score: 0.046
  28. Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment. EBioMedicine. 2016 Mar; 5:198-203.
    View in: PubMed
    Score: 0.042
  29. Outcomes of proton therapy for the treatment of uveal metastases. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1044-50.
    View in: PubMed
    Score: 0.038
  30. Aggressive skull base metastasis from uveal melanoma: a clinicopathologic study. Eur J Ophthalmol. 2014 Sep-Oct; 24(5):811-3.
    View in: PubMed
    Score: 0.037
  31. Proton beam irradiation for non-AMD CNV: 2-year results of a randomised clinical trial. Br J Ophthalmol. 2014 Sep; 98(9):1212-7.
    View in: PubMed
    Score: 0.037
  32. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012; 7(4):e35295.
    View in: PubMed
    Score: 0.032
  33. In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011 Jun 01; 52(6):3880-7.
    View in: PubMed
    Score: 0.030
  34. Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization. PLoS One. 2011 Apr 29; 6(4):e18864.
    View in: PubMed
    Score: 0.030
  35. Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2008 Nov; 49(11):5008-14.
    View in: PubMed
    Score: 0.025
  36. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci. 2008 Feb; 49(2):726-31.
    View in: PubMed
    Score: 0.024
  37. Endogenous endostatin inhibits choroidal neovascularization. FASEB J. 2007 Dec; 21(14):3809-18.
    View in: PubMed
    Score: 0.023
  38. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol. 2005 Apr; 123(4):509-16.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.